• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体 DNA 改变导致琥珀酸脱氢酶缺陷型肾细胞癌向有氧糖酵解的不可逆转变。

Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.

机构信息

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Molecular Medicine Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892, USA.

出版信息

Sci Signal. 2021 Jan 5;14(664):eabc4436. doi: 10.1126/scisignal.abc4436.

DOI:10.1126/scisignal.abc4436
PMID:33402335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8039187/
Abstract

Understanding the mechanisms of the Warburg shift to aerobic glycolysis is critical to defining the metabolic basis of cancer. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an aggressive cancer characterized by biallelic inactivation of the gene encoding the Krebs cycle enzyme fumarate hydratase, an early shift to aerobic glycolysis, and rapid metastasis. We observed impairment of the mitochondrial respiratory chain in tumors from patients with HLRCC. Biochemical and transcriptomic analyses revealed that respiratory chain dysfunction in the tumors was due to loss of expression of mitochondrial DNA (mtDNA)-encoded subunits of respiratory chain complexes, caused by a marked decrease in mtDNA content and increased mtDNA mutations. We demonstrated that accumulation of fumarate in HLRCC tumors inactivated the core factors responsible for replication and proofreading of mtDNA, leading to loss of respiratory chain components, thereby promoting the shift to aerobic glycolysis and disease progression in this prototypic model of glucose-dependent human cancer.

摘要

了解沃伯格(Warburg)向有氧糖酵解转变的机制对于确定癌症的代谢基础至关重要。遗传性平滑肌瘤病和肾细胞癌(HLRCC)是一种侵袭性癌症,其特征是编码克雷布斯循环酶富马酸水合酶的基因发生双等位基因失活,早期发生有氧糖酵解,并迅速转移。我们观察到 HLRCC 患者的肿瘤中线粒体呼吸链受损。生化和转录组学分析显示,肿瘤中的呼吸链功能障碍是由于线粒体 DNA(mtDNA)编码的呼吸链复合物亚基的表达缺失所致,这是由于 mtDNA 含量明显减少和 mtDNA 突变增加所致。我们证明,HLRCC 肿瘤中富马酸的积累使负责 mtDNA 复制和校对的核心因子失活,导致呼吸链成分丧失,从而促进有氧糖酵解,并在这个葡萄糖依赖性人类癌症的典型模型中促进疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/0c188eb94ce2/nihms-1671827-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/94830407f5ac/nihms-1671827-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/bc575df8ed98/nihms-1671827-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/de59482742dd/nihms-1671827-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/e38c49ba3c12/nihms-1671827-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/3447d43b9d81/nihms-1671827-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/7171841fb8af/nihms-1671827-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/0c188eb94ce2/nihms-1671827-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/94830407f5ac/nihms-1671827-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/bc575df8ed98/nihms-1671827-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/de59482742dd/nihms-1671827-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/e38c49ba3c12/nihms-1671827-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/3447d43b9d81/nihms-1671827-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/7171841fb8af/nihms-1671827-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a99d/8039187/0c188eb94ce2/nihms-1671827-f0007.jpg

相似文献

1
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.线粒体 DNA 改变导致琥珀酸脱氢酶缺陷型肾细胞癌向有氧糖酵解的不可逆转变。
Sci Signal. 2021 Jan 5;14(664):eabc4436. doi: 10.1126/scisignal.abc4436.
2
Fumarate hydratase as a therapeutic target in renal cancer.琥珀酸脱氢酶作为肾癌的治疗靶点。
Expert Opin Ther Targets. 2020 Sep;24(9):923-936. doi: 10.1080/14728222.2020.1804862. Epub 2020 Oct 6.
3
Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer.评估遗传性平滑肌瘤病和肾细胞癌的真实风险以及肾癌发展情况的复杂性。
Cancer. 2020 Aug 15;126(16):3617-3619. doi: 10.1002/cncr.32915. Epub 2020 May 15.
4
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.遗传性平滑肌瘤病和肾细胞癌:185 名受累个体队列的临床、分子和筛查特征。
Eur Urol Oncol. 2020 Dec;3(6):764-772. doi: 10.1016/j.euo.2019.11.002. Epub 2019 Dec 9.
5
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer.估计琥珀酸氢酶改变的携带频率及其对遗传性平滑肌瘤病和肾癌中肾癌风险的影响。
Cancer. 2020 Aug 15;126(16):3657-3666. doi: 10.1002/cncr.32914. Epub 2020 May 15.
6
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.UOK 262细胞系,延胡索酸水合酶缺陷(FH-/FH-)型遗传性平滑肌瘤病肾细胞癌:人类癌症中异常能量代谢途径的体外和体内模型
Cancer Genet Cytogenet. 2010 Jan 1;196(1):45-55. doi: 10.1016/j.cancergencyto.2009.08.018.
7
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.蛋白酶体抑制通过下调 p62 和 c-Myc 来破坏琥珀酸脱氢酶缺陷型肿瘤的代谢。
Sci Rep. 2019 Dec 5;9(1):18409. doi: 10.1038/s41598-019-55003-2.
8
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.使用新型烟酰胺磷酸核糖转移酶(NAMPT)抑制剂OT-82靶向FH缺陷型遗传性平滑肌瘤病和肾细胞癌中的NAD+代谢脆弱性。
Mol Cancer Ther. 2025 Feb 4;24(2):200-213. doi: 10.1158/1535-7163.MCT-24-0225.
9
Multiple cutaneous and uterine leiomyomatosis in a 36-year-old female, and discussion of hereditary leiomyomatosis and renal cell carcinoma.一名36岁女性的多发性皮肤和子宫平滑肌瘤病,以及遗传性平滑肌瘤病和肾细胞癌的讨论。
Int J Dermatol. 2012 Oct;51(10):1213-6. doi: 10.1111/j.1365-4632.2011.05456.x.
10
Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.遗传性平滑肌瘤病和肾癌(HLRCC)综合征中子宫平滑肌瘤的形态学和分子特征。
Am J Surg Pathol. 2013 Jan;37(1):74-80. doi: 10.1097/PAS.0b013e31825ec16f.

引用本文的文献

1
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skipping.靶向驱动遗传性平滑肌瘤病和肾细胞癌(HLRCC)导致外显子跳跃的致病性隐蔽外显子。
Mol Ther Nucleic Acids. 2025 Aug 5;36(3):102668. doi: 10.1016/j.omtn.2025.102668. eCollection 2025 Sep 9.
2
Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer.氧化代谢与糖酵解代谢:它们在癌症中的相互调节与失调
Cells. 2025 Jul 30;14(15):1177. doi: 10.3390/cells14151177.
3
Targeting metabolic and epigenetic reprogramming in metastatic fumarate hydratase-deficient renal cell carcinoma.

本文引用的文献

1
We need to talk about the Warburg effect.我们需要谈谈瓦伯格效应。
Nat Metab. 2020 Feb;2(2):127-129. doi: 10.1038/s42255-020-0172-2.
2
Tracing insights into de novo lipogenesis in liver and adipose tissues.追踪肝脏和脂肪组织中从头合成脂肪的见解。
Semin Cell Dev Biol. 2020 Dec;108:65-71. doi: 10.1016/j.semcdb.2020.02.012. Epub 2020 Mar 19.
3
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.遗传定义的肾脏肿瘤的生长速度:对主动监测和干预的影响。
靶向富马酸水合酶缺陷型转移性肾细胞癌中的代谢和表观遗传重编程。
Clin Exp Metastasis. 2025 Aug 8;42(5):47. doi: 10.1007/s10585-025-10368-9.
4
Association between fumarate hydratase variant subtypes and the risk of HLRCC-associated renal cell carcinoma: systematic review and meta-analysis.富马酸水合酶变异亚型与遗传性平滑肌瘤病肾细胞癌相关肾细胞癌风险之间的关联:系统评价与荟萃分析
Hum Genomics. 2025 Jul 21;19(1):83. doi: 10.1186/s40246-025-00797-8.
5
Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.贝伐单抗和厄洛替尼在肾髓质癌和富马酸水合酶缺乏性肾细胞癌临床前模型中的疗效差异
Mol Cancer Ther. 2025 Jul 2. doi: 10.1158/1535-7163.MCT-24-0703.
6
Organelle-oriented nanomedicines in tumor therapy: Targeting, escaping, or collaborating?肿瘤治疗中面向细胞器的纳米药物:靶向、逃逸还是协作?
Bioact Mater. 2025 Mar 13;49:291-339. doi: 10.1016/j.bioactmat.2025.02.040. eCollection 2025 Jul.
7
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities.糖酵解在肿瘤发生中的作用:从生物学角度到治疗机会。
Neoplasia. 2024 Dec;58:101076. doi: 10.1016/j.neo.2024.101076. Epub 2024 Oct 30.
8
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.使用新型烟酰胺磷酸核糖转移酶(NAMPT)抑制剂OT-82靶向FH缺陷型遗传性平滑肌瘤病和肾细胞癌中的NAD+代谢脆弱性。
Mol Cancer Ther. 2025 Feb 4;24(2):200-213. doi: 10.1158/1535-7163.MCT-24-0225.
9
Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance.三羧酸循环与非代谢过程的关系:一个关于 DNA 修复及其对癌症治疗耐药性影响的小故事。
Int J Mol Sci. 2024 Aug 21;25(16):9054. doi: 10.3390/ijms25169054.
10
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma.肾细胞癌中癌代谢物富马酸酯对RNA甲基化的重编程
NAR Cancer. 2024 Feb 7;6(1):zcae004. doi: 10.1093/narcan/zcae004. eCollection 2024 Mar.
J Clin Oncol. 2020 Apr 10;38(11):1146-1153. doi: 10.1200/JCO.19.02263. Epub 2020 Feb 21.
4
Growth factors stimulate anabolic metabolism by directing nutrient uptake.生长因子通过指导营养物质摄取来刺激合成代谢。
J Biol Chem. 2019 Nov 22;294(47):17883-17888. doi: 10.1074/jbc.AW119.008146. Epub 2019 Oct 18.
5
Redox Chemistry in the Genome: Emergence of the [4Fe4S] Cofactor in Repair and Replication.基因组中的氧化还原化学:[4Fe4S]辅因子在修复和复制中的出现。
Annu Rev Biochem. 2019 Jun 20;88:163-190. doi: 10.1146/annurev-biochem-013118-110644.
6
The Metabolic Basis of Kidney Cancer.肾脏癌的代谢基础。
Cancer Discov. 2019 Aug;9(8):1006-1021. doi: 10.1158/2159-8290.CD-18-1354. Epub 2019 May 14.
7
Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes.哺乳动物氧化磷酸化复合物 I-V 和超级复合物的组装。
Essays Biochem. 2018 Jul 20;62(3):255-270. doi: 10.1042/EBC20170098.
8
Early loss of mitochondrial complex I and rewiring of glutathione metabolism in renal oncocytoma.肾嗜酸细胞瘤中线粒体复合物 I 的早期缺失和谷胱甘肽代谢的重排。
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6283-E6290. doi: 10.1073/pnas.1711888115. Epub 2018 Jun 18.
9
ONC201 kills breast cancer cells by targeting mitochondria.ONC201通过靶向线粒体来杀死乳腺癌细胞。
Oncotarget. 2018 Apr 6;9(26):18454-18479. doi: 10.18632/oncotarget.24862.
10
Spatial orchestration of mitochondrial translation and OXPHOS complex assembly.线粒体翻译和 OXPHOS 复合物组装的空间协调。
Nat Cell Biol. 2018 May;20(5):528-534. doi: 10.1038/s41556-018-0090-7. Epub 2018 Apr 16.